Targeting Phage Therapy 2024 Agenda Has Been Released

  We invite you to the Phage Therapy 2024 Conference, a two-day event focused on the latest in phage research, current challenges, and future directions. This conference will bring together experts, researchers, and healthcare professionals to discuss phage therapy and its application in medicine. Day 1, Thursday June 20: Keynote Speech: Overview of phage, phageome,…

Phage-Microbiome Consortium: Interplay and Modulation in Human Health and Disease

In collaboration with the International Society of Microbiota (ISM), we are pleased to announce the launch of The Phage-Microbiome Consortium. Aim of the Consortium The aim of this project is to set up a consortium of experts in the field of bacteriophages and the human microbiome, to collectively explore the potential of phages in shaping…

The Concluding Remarks of Targeting Phage Therapy 2023 & Future Perspectives

The 6th World Congress on Targeting Phage Therapy 2023 that was held on June 1-2 in Paris, and gathered more than 150 attendees from 30+ different countries. Targeting Phage Therapy 2023 included more than 71 presentations between major talks, short orals, and posters. The Chairman of the scientific committee Dr. Marvin Edeas Université de Paris,…

Phiogen CEO was awarded the Phage Therapy 2023 Best Innovation for their technology platform

The Targeting Phage Therapy 2023 Best Scientific Contribution award was discerned to: Amanda (Curtis) Burkardt, CEO of PHIOGEN, USA Ms. Burkardt was awarded for creating patient ready products in a remedy ready world. Spun-off from of one of the US’s only phage therapy cores, TAILOR Labs at Baylor College of Medicine, an ambitious new biotech…

Martha Clokie Editor in Chief of PHAGE Journal was awarded the Phage Therapy 2023 Best Scientific Contribution

The Targeting Phage Therapy 2023 Best Scientific Contribution award was discerned to: Martha Clokie, Professor at University of Leicester and Editor in Chief of the PHAGE Journal Prof. Clokie was awarded for her talk on phage therapy challenges and opportunities. In her talk, she elaborated on her team’s work in an agricultural setting that has…

Phage Therapy 2023 Best Short Oral: Bacteriophage-Antibiotic Combination to Allow Liver Transplantation

The Targeting Phage Therapy 2023 Best Short Oral Presentation award was discerned to: Bacteriophage-Antibiotic Combination Therapy Against Extensively Drug-Resistant Pseudomonas Aeruginosa Infection to Allow Liver Transplantation in a Toddler Brieuc Van Nieuwenhuyse, UC Louvain, Belgium Dr. Van Nieuwenhuyse explained to Targeting Phage Therapy: “My research focuses on bidirectional translational research, trying to analyze specific mechanisms…

Targeting Phage Therapy 2023 Best Poster: Thermostable Bactericidal Endolysin Discovery

The Targeting Phage Therapy 2023 Best Poster Presentation award was discerned to: New Ways to Fight Bacterial Pathogens: Metagenomics Analysis for the Discovery of a Thermostable Endolysin With High Bactericidal Activity Panagiota Pantiora, Agricultural University of Athens, Greece Ms. Pantiora is currently a PhD student in Enzyme Biotechnology, at the Laboratory of Enzyme Technology of AUA,…

PHAGE Therapy, Applications, and Research Journal is a contributing partner

PHAGE Therapy, Applications, and Research Journal is a contributing partner of Targeting Phage Therapy 2023 Conference.  Editor in Chief Prof. Martha Clokie from the University of Leicester will be presenting an introductory talk on  the “Challenges and Opportunities for Bacteriophage Therapy”. All the conference proceedings will be published in the journal. So make sure to…